Analyst Price Targets — BCPC
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| October 26, 2026 10:58 am | Raghuram Selvaraju | H.C. Wainwright | $210.00 | $177.00 | StreetInsider | Balchem (BCPC) PT Lowered to $210 at H.C. Wainwright |
| August 3, 2026 10:56 am | Raghuram Selvaraju | H.C. Wainwright | $215.00 | $167.56 | StreetInsider | Balchem (BCPC) PT Raised to $215 at H.C. Wainwright |
| August 3, 2026 10:07 am | — | UBS | $215.00 | $167.56 | TheFly | Balchem price target raised to $215 from $190 at H.C. Wainwright |
| December 5, 2025 10:13 am | — | Redburn Partners | $162.00 | $153.35 | TheFly | Balchem initiated with a Neutral at Rothschild & Co Redburn |
| August 4, 2025 12:27 pm | — | H.C. Wainwright | $189.00 | $155.39 | TheFly | Balchem price target raised to $189 from $180 at H.C. Wainwright |
| April 28, 2025 10:07 am | Raghuram Selvaraju | H.C. Wainwright | $180.00 | $153.64 | TheFly | Balchem price target lowered to $180 from $190 at H.C. Wainwright |
| November 5, 2024 11:41 am | Raghuram Selvaraju | H.C. Wainwright | $190.00 | $175.31 | StreetInsider | Balchem (BCPC) PT Raised to $190 at H.C. Wainwright |
| May 2, 2022 6:11 am | — | H.C. Wainwright | $152.00 | $123.20 | Benzinga | HC Wainwright & Co. Maintains Buy on Balchem, Lowers Price Target to $152 |
Latest News for BCPC
MONTVALE, N.J., Oct. 28, 2026 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will participate in Baird's Global Industrial Conference on November 11, 2026.
Despite the Federal Reserve's decision to raise interest rates in September 2026, inflation crept up again that month, with the Consumer Price Index rising 0.6% compared to 0.4% in August. Not all goods—and therefore not all companies—will experience the same impact, and energy and gasoline prices have been among the fastest to rise.
Balchem posted strong sales growth of 8.6% during the quarter and free cash flow of $57.9 million. BCPC's business is great—growing earnings, low borrowings, and continuous share buybacks. My DCF valuation states the stock should be priced at roughly $88. The current price of $177 reflects an overvaluation of roughly 50%.
Third-quarter net sales rose 8.6% year over year to $291 million. Human nutrition and health segment sales increased 8.1% to $188 million.
Balchem Corporation (BCPC) Q3 2026 Earnings Call Transcript
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.